Use of a Hydrogen, Potassium-ATPase inhibitor in the treatment of nasal polyps, asthma and Widal's syndrome

摘要

Use of an H+, K+-ATPase inhibitor and optionally a glucocorticoid, (preferably an anti-inflammatory steroid) for the treatment of nasal polyps, Widal's Syndrome, and asthma. The administration of the inhibitor and glucocorticoid can be simultaneous, separate or sequential.